Rescue of Monocrotaline-Induced Pulmonary Arterial Hypertension Using Bone Marrow–Derived Endothelial-Like Progenitor Cells: Efficacy of Combined Cell and eNOS Gene Therapy in Established Disease

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Circulation Research

• Publication date

  2005-03-04

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1161/01.RES.0000157672.70560.7bPMID 15692087
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pathology of pulmonary hypertension.

  2007cited by this paper
• Cell therapy for pulmonary hypertension: what is the true potential of endothelial progenitor cells?

  2004cited by this paper
• Pathology of pulmonary hypertension.

  2004cited by this paper
• Defective Lung Vascular Development and Fatal Respiratory Distress in Endothelial NO Synthase–Deficient Mice: A Model of Alveolar Capillary Dysplasia?

  2004cited by this paper
• Endothelial progenitor cells for postnatal vasculogenesis.

  2004cited by this paper
• Life after corpse engulfment: phagocytosis of apoptotic cells leads to VEGF secretion and cell growth

  2004cited by this paper
• Cardiovascular Effects of Systemic Nitric Oxide Synthase Inhibition With Asymmetrical Dimethylarginine in Humans

  2004cited by this paper
• Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells.

  2004cited by this paper
• Role of nitric oxide in tumor angiogenesis.

  2004cited by this paper
• Hybrid Cell–Gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor Cells

  2003cited by this paper
• NO and angiogenesis.

  2003cited by this paper
• Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.

  2003cited by this paper
• Angiogenesis Induced by Endothelial Nitric Oxide Synthase Gene Through Vascular Endothelial Growth Factor Expression in a Rat Hindlimb Ischemia Model

  2003cited by this paper
• Protective Role of Angiopoietin-1 in Experimental Pulmonary Hypertension

  2003cited by this paper
• Janus face of vascular endothelial growth factor: The obligatory survival factor for lung vascular endothelium controls precapillary artery remodeling in severe pulmonary hypertension

  2002cited by this paper
• Vascular progenitors: from biology to treatment.

  2002cited by this paper
• BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives

  2002cited by this paper
• Contribution of marrow-derived progenitors to vascular and cardiac regeneration.

  2002cited by this paper
• Incidence of alveolar capillary dysplasia in severe idiopathic persistent pulmonary hypertension of the newborn

  2002cited by this paper
• Overexpression of endothelial NO synthase induces angiogenesis in a co-culture model.

  2002cited by this paper
• Stomach gas laboratory in critical care.

  2002cited by this paper
• Genetic aspect of pulmonary arterial hypertension

  2001cited by this paper
• Cell-Based Gene Transfer of Vascular Endothelial Growth Factor Attenuates Monocrotaline-Induced Pulmonary Hypertension

  2001cited by this paper
• Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells From Patients With Primary Pulmonary Hypertension to Transforming Growth Factor-&bgr;1 and Bone Morphogenetic Proteins

  2001cited by this paper
• Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death‐dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

  2001cited by this paper
• Genetic aspects of pulmonary arterial hypertension.

  2001cited by this paper
• Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension

  2000cited by this paper
• Primary pulmonary hypertension: a vascular biology and translational research "Work in progress".

  2000cited by this paper
• Congenital Misalignment of Pulmonary Veins with Alveolar Capillary Dysplasia Causing Persistent Neonatal Pulmonary Hypertension: Report of Two Affected Siblings

  2000cited by this paper
• Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

  2000cited by this paper
• Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension.

  1999cited by this paper
• Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers. Evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth.

  1999cited by this paper
• New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF

  1999cited by this paper
• Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis.

  1997cited by this paper
• Monocrotaline-induced renal lesions.

  1983cited by this paper
• Arterial degeneration and glomerular hyalinization in the kidney of monocrotaline-intoxicated rats.

  1970cited by this paper

• Study of Angiogenic Cell Therapy for Progressive Pulmonary Arterial Hypertension: Intervention with Repeat Dosing of eNOS-enhanced EPCs: the SAPPHIRE Trial.

  2025cites this paper
• Drugs targeting novel pathways in pulmonary arterial hypertension

  2025cites this paper
• Bidirectional Regulation of Nitric Oxide and Endothelin-1 in Cerebral Vasospasm: Mechanisms and Therapeutic Perspectives

  2025cites this paper
• Differentiation of lung tissue-resident c-Kit+ cells into microvascular endothelial cells alleviates pulmonary vascular remodeling.

  2025cites this paper
• Management of Pulmonary Arterial Hypertension: Current Strategies and Future Prospects

  2025cites this paper
• Chronic intermittent hypobaric hypoxia prevents pulmonary arterial hypertension through maintaining eNOS homeostasis.

  2025cites this paper
• Endothelial progenitor cells for diabetic cardiac and kidney disease

  2024cites this paper
• Stem cells in pulmonary hypertension: Current understanding and future challenges

  2024cites this paper
• Stem cell therapy in pulmonary hypertension: current practice and future opportunities

  2023cites this paper
• Endothelial progenitor cells derived from embryonic stem cells prevent alveolar simplification in a murine model of bronchopulmonary dysplasia

  2023cites this paper
• PDK1 upregulates PINK1-mediated pulmonary endothelial cell mitophagy during hypoxia-induced pulmonary vascular remodeling

  2023cites this paper
• Endothelial progenitor cell-derived exosomes inhibit pulmonary artery smooth muscle cell in vitro proliferation and resistance to apoptosis by modulating the Mitofusin-2 and Ras-Raf-ERK1/2 signaling pathway.

  2023cites this paper
• Emerging biologics for the treatment of pulmonary arterial hypertension

  2023cites this paper
• Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension

  2023cites this paper
• Pulmonary hypertension: modern methods of treatment and ways of their long-term development.

  2023cites this paper
• What is the need and why is it time for innovative models for understanding lung repair and regeneration?

  2023cites this paper
• Stem cell therapy for pulmonary arterial hypertension: An update.

  2022cites this paper
• Endothelial Senescence: A New Age in Pulmonary Hypertension

  2022cites this paper
• Radiation-induced cardiac side-effects: The lung as target for interacting damage and intervention

  2022cites this paper
• Single-cell microencapsulation improves lung retention of endothelial colony forming cells after intravascular delivery and unmasks therapeutic benefit in severe pulmonary arterial hypertension

  2022cites this paper
• Targeting extracellular vesicle delivery to the lungs by microgel encapsulation

  2022cites this paper
• A Tm4sf1-Marked Subpopulation of Endothelial Stem/Progenitor Cells Identified by Lung Single-Cell Omics of Pulmonary Arterial Hypertension

  2022cites this paper
• Pulmonary Arterial Hypertension

  2021cites this paper
• "NOVEL MECHANISMS TARGETED BY DRUG TRIALS IN PULMONARY ARTERIAL HYPERTENSION".

  2021cites this paper
• Novel Pharmacological Targets for Pulmonary Arterial Hypertension.

  2021cites this paper
• Endothelial cells in the pathogenesis of pulmonary arterial hypertension

  2021cites this paper
• Therapeutic Potential of Endothelial Progenitor Cells in Pulmonary Diseases.

  2021cites this paper
• Pediatric Pulmonary Hypertension: Definitions, Mechanisms, Diagnosis, and Treatment.

  2021cites this paper
• Genetic Delivery and Gene Therapy in Pulmonary Hypertension

  2021cites this paper
• Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats

  2021cites this paper
• Inflammation in Pulmonary Arterial Hypertension.

  2021cites this paper
• Endothelial progenitor cells in pulmonary diseases, repair and regeneration

  2021cites this paper
• Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension

  2021cites this paper
• ACE2 gene transfer ameliorates vasoreparative dysfunction in CD34+ cells derived from diabetic older adults

  2021cites this paper
• Chronic Pulmonary Hypertension

  2020cites this paper
• Stem/Progenitor Cells and Pulmonary Arterial Hypertension.

  2020cites this paper
• Beyond Thrombosis: the Role of Platelets in Pulmonary Hypertension

  2020cites this paper
• Evidence of Accumulated Endothelial Progenitor Cells in the Lungs of Rats with Pulmonary Arterial Hypertension by 89Zr-oxine PET Imaging

  2020cites this paper
• Schistosomiasis-associated pulmonary arterial hypertension: a systematic review

  2020cites this paper
• Current and emerging therapeutic approaches to pulmonary hypertension

  2020cites this paper
• A non-selective endothelin receptor antagonist bosentan modulates kinetics of bone marrow-derived cells in ameliorating pulmonary hypertension in mice

  2020cites this paper
• Forced Overexpression of Translationally Controlled Tumor Protein ( TCTP / TPT 1 ) Induces a Growth-Dysregulated Phenotype in Endothelial and Smooth Muscle Cells : Role of TCTP Exosomal Export in Paracrine Cell-Cell Signaling Induced by Endothelial Injury

  2019cites this paper
• The Search for Disease-Modifying Therapies in Pulmonary Hypertension

  2019cites this paper
• Stem Cell Biology and the Cardiovascular System

  2019cites this paper
• Chapter 4 Nitric Oxide in Pathophysiology and Treatment of Pulmonary Hypertension

  2019cites this paper
• Combination Therapy Improves Vascular Volume in Female Rats with Pulmonary Hypertension.

  2019cites this paper
• Medical Therapy for Heart Failure Associated With Pulmonary Hypertension.

  2019cites this paper
• BMPR2‐expressing bone marrow‐derived endothelial‐like progenitor cells alleviate pulmonary arterial hypertension in vivo

  2019cites this paper
• Radiation-induced cardiopulmonary dysfunction

  2019cites this paper
• Regenerative cell therapy for pulmonary arterial hypertension in animal models: a systematic review

  2019cites this paper
• Potentiel thérapeutique des progeniteurs endothéliaux dans le traitement de la défaillance ventriculaire droite secondaire à l'hypertension pulmonaire

  2019cites this paper
• Myeloid angiogenic cells exhibit impaired migration, reduced expression of endothelial markers, and increased apoptosis in idiopathic pulmonary arterial hypertension 1.

  2019cites this paper
• Targeted Delivery of Sildenafil for Inhibiting Pulmonary Vascular Remodeling

  2019cites this paper
• Peripheral Blood Stem Cells

  2019cites this paper
• Translating Basic Research into Safe and Effective Cell-based Treatments for Respiratory Diseases.

  2019cites this paper
• New and Emerging Therapies for Pulmonary Arterial Hypertension.

  2019cites this paper
• Involvement of miR‐200b–PKCα signalling in pulmonary hypertension in cor pulmonale model

  2019cites this paper
• Paving the Road for Mesenchymal Stem Cell-Derived Exosome Therapy in Bronchopulmonary Dysplasia and Pulmonary Hypertension

  2019cites this paper
• Blood outgrowth endothelial cells overexpressing eNOS mitigate pulmonary hypertension in rats: a unique carrier cell enabling autologous cell-based gene therapy.

  2019cites this paper
• Draft Myeloid angiogenic cells exhibit impaired migration , reduced expression of endothelial markers and increased apoptosis in idiopathic pulmonary arterial hypertension

  2018cites this paper
• Endothelial nitric oxide synthase overexpressing human early outgrowth cells inhibit coronary artery smooth muscle cell migration through paracrine functions

  2018cites this paper
• Endothelial Cell Metabolism.

  2018cites this paper
• Hypoxia induces the dysfunction of human endothelial colony-forming cells via HIF-1α signaling.

  2018cites this paper
• Stem cell therapy targeting the right ventricle in pulmonary arterial hypertension: is it a potential avenue of therapy?

  2018cites this paper
• Blood Outgrowth and Proliferation of Endothelial Colony Forming Cells are Related to Markers of Disease Severity in Patients with Pulmonary Arterial Hypertension

  2018cites this paper
• Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice

  2018cites this paper
• Myeloid-Derived Suppressor Cells and Pulmonary Hypertension

  2018cites this paper
• A pro-con debate: current controversies in PAH pathogenesis at the American Thoracic Society International Conference in 2017.

  2018cites this paper
• Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats

  2018influential citation
• Intratracheal Administration of Autologous Bone Marrow-Derived Cells Ameliorates Monocrotaline-Induced Pulmonary Vessel Remodeling and Lung Inflammation in Rats

  2018cites this paper
• Title Adipose-derived regenerative cell therapy inhibits the progression ofmonocrotaline-induced pulmonary hypertension in rats

  2018cites this paper
• Bone Marrow-Derived Endothelial Progenitor Cells Contribute to Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibition of Store-Operated Ca2+ Channels

  2018cites this paper
• EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

  2018cites this paper
• Reactive Oxygen and Nitrogen Species in the Development of Pulmonary Hypertension

  2017cites this paper
• Combination treatment of adipose-derived stem cells and adiponectin attenuates pulmonary arterial hypertension in rats by inhibiting pulmonary arterial smooth muscle cell proliferation and regulating the AMPK/BMP/Smad pathway

  2017cites this paper
• Hemodynamic, biological, and right ventricular functional changes following intraatrial shunt repair in patients with flow‐induced pulmonary hypertension

  2017cites this paper
• Optimal Dose and Timing of Umbilical Stem Cells Treatment in Pulmonary Arterial Hypertensive Rats

  2017cites this paper
• Pinocembrin ex vivo preconditioning improves the therapeutic efficacy of endothelial progenitor cells in monocrotaline‐induced pulmonary hypertension in rats

  2017cites this paper
• Adipose-derived stem cell transplantation in treating monocrotaline-induced pulmonary arterial hypertension

  2017cites this paper
• Response to "Comment to the article 'Diverse contribution of bone marrow-derived late-outgrowth endothelial progenitor cells to vascular repair under pulmonary arterial hypertension and arterial neointimal formation'".

  2017cites this paper
• Genistein attenuates monocrotaline-induced pulmonary arterial hypertension in rats by activating PI3K/Akt/eNOS signaling.

  2017cites this paper
• A Novel CXCR4 antagonist enhances angiogenesis via modifying the ischaemic tissue environment

  2017cites this paper
• Enhancing Blood Outgrowth Endothelial Cells for Optimal Coating of Blood Contacting Surfaces

  2017cites this paper
• The influence of sex on the in vivo and in vitro effects of treprostinil in pulmonary arterial hypertension

  2017cites this paper
• Therapeutic benefits of intravenous cardiosphere-derived cell therapy in rats with pulmonary hypertension

  2017cites this paper
• Vascular aging: Molecular mechanisms and potential treatments for vascular rejuvenation.

  2017cites this paper
• Regenerative Potential of Mesenchymal Stem Cells: Therapeutic Applications in Lung Disorders

  2017cites this paper
• Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model

  2017cites this paper
• Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension

  2017cites this paper
• Effects of Transplanted Human Cord Blood-Mononuclear Cells on Pulmonary Hypertension in Immunodeficient Mice and Their Distribution.

  2017cites this paper
• Novel Therapeutic Strategies for the Treatment of Pulmonary Arterial Hypertension

  2017cites this paper
• Pulmonary Hypertension Associated with Idiopathic Pulmonary Fibrosis: Current and Future Perspectives

  2017cites this paper
• Proliferative Versus Degenerative Paradigms in Pulmonary Arterial Hypertension: Have We Put the Cart Before the Horse?

  2017cites this paper
• Regeneration of the lung: Lung stem cells and the development of lung mimicking devices

  2016cites this paper
• Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction

  2016cites this paper
• Conditioned Medium from Early-Outgrowth Bone Marrow Cells Is Retinal Protective in Experimental Model of Diabetes

  2016cites this paper
• Prominin-1/CD133 expression as potential tissue-resident vascular endothelial progenitor cells in the pulmonary circulation.

  2016cites this paper
• Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD

  2016cites this paper
• Lung stem cell update: promise and controversy.

  2016cites this paper
• Therapeutic potential of adipose stem cell‐derived conditioned medium against pulmonary hypertension and lung fibrosis

  2016cites this paper